Sensitive Determination of Terazosin in Pharmaceutical Formulations and Biological Samples by Ionic-Liquid Microextraction Prior to Spectrofluorimetry

Table 3

Determination of terazosin in spiked urine and spiked plasma by present work.

Drug		Spiked urine			Spiked plasma
	Amount added (μg L^−1)	Amount found (μg L^−1) ± S.D.^a	Recovery (%)	Amount added (μg L^−1)	Amount found (μg L^−1) ± S.D.^a	Recovery (%)
Terazosin	2	1.83±0.09	91.5	2	1.73±0.11	86.5
	5	4.81±0.28	96.2	5	4.82±0.33	96.4
	10	9.40±0.30	94.0	10	9.60±0.51	96.0
	100	105.81±4.11	105.8	100	93.10±4.88	93.1

^aAverage of three independent measurements.